abstract |
The invention relates to a liquid composition comprising a combination of Δ 9 -tetrahydrocannabinol (THC) and cannabidiol (CBD) and an oral delivery system, methods of treating pain, inflammation and/or anxiety in a subject and methods of controlling a heart rate of a subject comprising orally administering the liquid composition, as well as downregulating or upregulating expression of particular related genes. |